Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tharmini Sundralingam"'
Identifying the strains of dengue circulating in the western province of Sri Lanka during 2019-2022.
Autor:
Harshi Abeygoonawardena, Kanchana Dassanayake, Jayani Kariyawasam, Teshan Chathuranga, Tharmini Sundralingam, Hansani Gunasekara, Sathyani Wevita, Gayani Premawansa, Sunil Premawansa, Ananda Wijewickrama, Namal Wijesinghe, Varuna Navaratne, Daniela Weiskopf, Alessandro Sette, Chandanamali Punchihewa, Aruna Dharshan De Silva
Publikováno v:
PLOS Global Public Health, Vol 4, Iss 7, p e0003150 (2024)
A study conducted from July 2019 to May 2022 at several hospitals in the Western Province, Sri Lanka, focused on dengue virus strains during the COVID-19 pandemic. Among 417 febrile patients, 47% were PCR-positive for dengue. Serotyping revealed DENV
Externí odkaz:
https://doaj.org/article/c6166e59714e401b88d2852118f92031
Autor:
Saumya Madushani Samarasinghe, Tharmini Sundralingam, Asanka Sudeshini Hewage, K.S.H. de Silva, Kamani Hemamala Tennekoon
Publikováno v:
Growth hormoneIGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. 62
To identify and characterize a novel deletion at the LHX4 gene locus in a proband with growth hormone deficiency (GHD).Long range polymerase chain reaction (PCR) amplification was used to confirm the suspected deletion and to identify the rough locat
Autor:
Sudeshini Hewage, Sumadee De Silva, Ruwandi Ranasinghe, Kamani H. Tennekoon, Tharmini Sundralingam, Shamya De Silva
Publikováno v:
Growth Hormone & IGF Research. :94-101
Objective Characterization of a deletion in the exon 1 and 5′ regulatory region of the GHRHR gene in a proband with isolated growth hormone deficiency. Methods Multiple ligation dependent probe amplification (MLPA) assay was carried out to confirm
Publikováno v:
Growth Hormone & IGF Research. 36:22-29
Objective Genetic alterations in GH1 and GHRHR genes are known to cause isolated growth hormone deficiency (IGHD). Of these, GHRHR codon 72 mutation has been reported to be highly prevalent in the Indian subcontinent, but among Sri Lankans its preval
Autor:
A.S. Hewage, Tharmini Sundralingam, Merenchi Arachchige Yasantha Ariyaratne, Kamani H. Tennekoon, Ishani Wickramage
Publikováno v:
Breast Cancer: Targets and Therapy. 9:111-120
INTRODUCTION AND AIMS Tamoxifen is an adjuvant drug effective in treating hormone receptor - positive breast cancer. However, 30%-50% of patients relapse and many develop adverse effects, such as hot flashes and fatty liver. Allelic variations alteri
Autor:
Tharmini Sundralingam, M.E.C. Muhandiram, K S H de Silva, B. Navarathne, A.S. Hewage, H D Jayasinghe, W. S. L. De Silva, D Ganihigama, Kamani H. Tennekoon
Publikováno v:
The Ceylon medical journal. 61(1)
Growth hormone releasing hormone receptor (GHRH-R) codon 72 mutation is recognised as a common genetic cause of growth hormone deficiency (GHD) in the Indian subcontinent resulting in a characteristic lean phenotype. Genetic studies have not been pre
Autor:
Manoharan, Vahinipriya1 (AUTHOR), Karunanayake, Eric Hamilton1 (AUTHOR), Tennekoon, Kamani Hemamala1 (AUTHOR), De Silva, Sumadee1 (AUTHOR) sum@ibmbb.cmb.ac.lk, Imthikab, Ahamed Ilyas Ahamed1 (AUTHOR), De Silva, Kanishka2 (AUTHOR), Angunawela, Preethika3 (AUTHOR), Vishwakula, Sameera4 (AUTHOR), Lunec, John5 (AUTHOR)
Publikováno v:
BMC Cancer. 1/30/2020, Vol. 20 Issue 1, p1-15. 15p. 4 Charts, 4 Graphs.